These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17645713)

  • 1. Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression.
    Yamani MH; Taylor DO; Haire C; Smedira N; Starling RC
    Clin Transplant; 2007; 21(4):523-5. PubMed ID: 17645713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant vasculopathy is associated with increased AlloMap gene expression score.
    Yamani MH; Taylor DO; Rodriguez ER; Cook DJ; Zhou L; Smedira N; Starling RC
    J Heart Lung Transplant; 2007 Apr; 26(4):403-6. PubMed ID: 17403484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1.
    Yamani MH; Ratliff NB; Cook DJ; Tuzcu EM; Yu Y; Hobbs R; Rincon G; Bott-Silverman C; Young JB; Smedira N; Starling RC
    J Am Coll Cardiol; 2005 Sep; 46(6):1029-35. PubMed ID: 16168287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection.
    Yamani MH; Cook DJ; Rodriguez ER; Thomas DM; Gupta S; Alster J; Taylor DO; Hobbs R; Young JB; Smedira N; Starling RC
    J Heart Lung Transplant; 2006 Nov; 25(11):1283-9. PubMed ID: 17097490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course.
    Koch A; Burgschweiger A; Herpel E; Sack FU; Schirmacher P; Szabo GB; Karck M; Schnabel PA
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):639-43. PubMed ID: 17689088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor gender on cardiac peri-transplantation ischemia injury.
    Yamani MH; Erinc SK; McNeill A; Ratliff NB; Sendrey D; Zhou L; Cook DJ; Hobbs R; Rincon G; Bott-Silverman C; Young JB; Banbury M; Navia J; Smedira N; Starling RC
    J Heart Lung Transplant; 2005 Nov; 24(11):1741-4. PubMed ID: 16297774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quilty in biopsy is associated with poor prognosis after heart transplantation.
    Hiemann NE; Knosalla C; Wellnhofer E; Lehmkuhl HB; Hetzer R; Meyer R
    Transpl Immunol; 2008 Jul; 19(3-4):209-14. PubMed ID: 18617005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial.
    Pham MX; Deng MC; Kfoury AG; Teuteberg JJ; Starling RC; Valantine H
    J Heart Lung Transplant; 2007 Aug; 26(8):808-14. PubMed ID: 17692784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epoxygenases belonging to CYP2 family in rat myocardial ischemia/reperfusion injury in vivo.
    Ao Y; Peng RX; Yang J; Wang BH; Falck JR; Dan H; Liu YH
    Saudi Med J; 2008 Jan; 29(1):23-9. PubMed ID: 18176666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of heart failure etiology on arterial wave reflection in heart transplant recipients: relation with C-reactive protein.
    Pierce GL; Schofield RS; Nichols WW; Hill JA; Braith RW
    J Hypertens; 2007 Nov; 25(11):2273-9. PubMed ID: 17921822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.
    Russo MJ; Hong KN; Davies RR; Chen JM; Sorabella RA; Ascheim DD; Williams MR; Gelijns AC; Stewart AS; Argenziano M; Naka Y
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1425-32.e1-3. PubMed ID: 19931672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac allograft systolic function. Is the aetiology (ischaemic or idiopathic) a determinant of ventricular function in the heart transplant patient?
    Antunes MJ; Biernat M; Sola E; Oliveira L; Prieto D; Franco F; Providência LA
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):586-90; discussion 590. PubMed ID: 18469010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients.
    Dijke IE; Caliskan K; Korevaar SS; Maat AP; Zondervan PE; Balk AH; Weimar W; Baan CC
    Transpl Immunol; 2008 Jan; 18(3):250-4. PubMed ID: 18047933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quilty indicates increased risk for microvasculopathy and poor survival after heart transplantation.
    Hiemann NE; Knosalla C; Wellnhofer E; Lehmkuhl HB; Hetzer R; Meyer R
    J Heart Lung Transplant; 2008 Mar; 27(3):289-96. PubMed ID: 18342751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.